axitinib 5 MG Oral Tablet [Inlyta]

RxCUI
1243014
RxNorm name
axitinib 5 MG Oral Tablet [Inlyta]
Display name
INLYTA (Oral Pill)
Full name
axitinib 5 MG Oral Tablet [Inlyta]
Term type
SBD
Status
Active
Strength
5 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-11-19 15:40:56

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032012
Active start
032012
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
axitinib5 MG / 1 EACHaxitinibaxitinib

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
axitinib1242999

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRInlyta 5 MG Oral Tablet1NAMES
RxNorm Nameaxitinib 5 MG Oral Tablet [Inlyta]1NAMES
RxNorm SynonymInlyta 5 MG Oral Tablet1NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID
2 linked values
2CODES
RxCUI12430141CODES
MMSL_CODEBD273401CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0069-0151-110069-0151INLYTA axitinibPfizer Laboratories Div Pfizer IncNDA202324
63539-044-0263539-044INLYTA axitinibU.S. PharmaceuticalsNDA202324

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA2023240069-0151INLYTA axitinibNDAPfizer Laboratories Div Pfizer Inc

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 3 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00069015111rxnav_ndcsyes
63539004401rxnav_ndcsyes
63539004402rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
INLYTAAXITINIBU.S. Pharmaceuticals8a903e31-936e-4ed7-8a59-59f32374f3382026-03-12Warnings, Adverse reactionsExact identifier
ndc (package): 63539-044-02
ndc (product): 63539-044
ndc11 (package): 63539004401
ndc11 (package): 63539004402
rxcui: 1243014
INLYTAAXITINIBPfizer Laboratories Div Pfizer Inc84137882-e000-47da-bd5b-fa76ab3c76f92025-02-19Warnings, Adverse reactionsExact identifier
ndc (package): 0069-0151-11
ndc (product): 0069-0151
ndc11 (package): 00069015111
rxcui: 1243014

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
84137882-e000-47da-bd5b-fa76ab3c76f9Inlyta 5 MG Oral Tablet [PSN] · axitinib 5 MG Oral Tablet [Inlyta] [SBD] · Inlyta 5 MG Oral Tablet [SY]324These highlights do not include all the information needed to use INLYTA safely and effectively. See full prescribing information for INLYTA. INLYTA ® (axitinib) tablets, for oral administration Initial U.S. Approval: 201220250219
8a903e31-936e-4ed7-8a59-59f32374f338Inlyta 5 MG Oral Tablet [PSN] · axitinib 5 MG Oral Tablet [Inlyta] [SBD] · Inlyta 5 MG Oral Tablet [SY]312These highlights do not include all the information needed to use INLYTA safely and effectively. See full prescribing information for INLYTA. INLYTA ® (axitinib) tablets, for oral administration Initial U.S. Approval: 201220260312

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
8a903e31-936e-4ed7-8a59-59f32374f338These highlights do not include all the information needed to use INLYTA safely and effectively. See full prescribing information for INLYTA. INLYTA ® (axitinib) tablets, for oral administration Initial U.S. Approval: 2012U.S. Pharmaceuticals20260312
84137882-e000-47da-bd5b-fa76ab3c76f9These highlights do not include all the information needed to use INLYTA safely and effectively. See full prescribing information for INLYTA. INLYTA ® (axitinib) tablets, for oral administration Initial U.S. Approval: 2012Pfizer Laboratories Div Pfizer Inc | Upjohn Manufacturing Ireland Unlimited Company | Pfizer Manufacturing Deutschland GmbH | Pfizer Ireland Pharmaceuticals Unlimited Company20250219
0f632aa1-5f36-41cd-bd63-f933ceb21c26National Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCL01EKVascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitorsATC1-4axitinib
FDASPLN0000175605Kinase InhibitorEPChas_epcaxitinib
FDASPLN0000020000Receptor Tyrosine Kinase InhibitorsMOAhas_moaaxitinib
MEDRTD000077784AxitinibCHEMhas_ingredientaxitinib
MEDRTD002292Carcinoma, Renal CellDISEASEmay_treataxitinib
MEDRTN0000020000Receptor Tyrosine Kinase InhibitorsMOAhas_moaaxitinib
MEDRTN0000175672Cellular Proliferation AlterationPEhas_peaxitinib

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH5 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESNDANDA202324
NAMESPrescribable SynonymInlyta 5 MG Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon